Discover UK Penny Stocks To Watch In December 2024

In This Article:

As the FTSE 100 and FTSE 250 indices face downward pressure due to weak trade data from China, investors are looking for alternative opportunities in the UK market. Penny stocks, often associated with smaller or newer companies, offer a unique opportunity for growth at lower price points. Despite being considered a somewhat outdated term, these stocks can still present significant potential when backed by strong financials and solid fundamentals.

Top 10 Penny Stocks In The United Kingdom

Name

Share Price

Market Cap

Financial Health Rating

ME Group International (LSE:MEGP)

£2.245

£845.83M

★★★★★★

Next 15 Group (AIM:NFG)

£4.335

£431.14M

★★★★☆☆

Secure Trust Bank (LSE:STB)

£3.57

£68.08M

★★★★☆☆

Serabi Gold (AIM:SRB)

£0.99

£74.98M

★★★★★★

Ultimate Products (LSE:ULTP)

£1.20

£102.41M

★★★★★★

Luceco (LSE:LUCE)

£1.30

£200.5M

★★★★★☆

Stelrad Group (LSE:SRAD)

£1.38

£175.75M

★★★★★☆

Tristel (AIM:TSTL)

£4.20

£200.31M

★★★★★★

Integrated Diagnostics Holdings (LSE:IDHC)

$0.4125

$239.8M

★★★★★★

FRP Advisory Group (AIM:FRP)

£1.48

£365.3M

★★★★★★

Click here to see the full list of 465 stocks from our UK Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Cirata

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Cirata plc, along with its subsidiaries, develops and provides collaboration software across North America, Europe, China, and internationally with a market cap of £33.28 million.

Operations: The company generates revenue primarily from the development and sale of licenses for software, along with related maintenance and support services, totaling $7.14 million.

Market Cap: £33.28M

Cirata plc, with a market cap of £33.28 million, has been actively expanding its cloud migration services through strategic partnerships, notably with TD SYNNEX and IBM. Despite generating US$7.14 million in revenue from software licenses and support services, the company remains unprofitable and is not expected to achieve profitability in the near term. Recent management changes include new board appointments and a transition in CFO roles aimed at stabilizing operations during challenging times. While Cirata's share price has been volatile and shareholders experienced dilution, its short-term assets comfortably cover liabilities, providing some financial stability amidst ongoing challenges.

AIM:CRTA Financial Position Analysis as at Dec 2024
AIM:CRTA Financial Position Analysis as at Dec 2024

Cairn Homes

Simply Wall St Financial Health Rating: ★★★★★☆